secwatch.observer — SEC 8-K summary
======================================

Issuer:     INOVIO PHARMACEUTICALS, INC. (INO)
CIK:        0001055726
Form:       8-K
Filed at:   2026-07-29T20:03:42+00:00
Accession:  0001193125-26-323628
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

Inovio reports preliminary Q2 2026 cash balance of $36.7M
---------------------------------------------------------

- Cash and cash equivalents estimated at $36.7 million as of June 30, 2026.
- Preliminary unaudited data subject to completion of financial closing procedures.
- No other financial results or guidance provided in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1055726/000119312526323628/0001193125-26-323628-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1055726/000119312526323628/d158934d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-323628

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer